Kingdom
Pseudomonadati
Phylum
Pseudomonadota
Class
Gammaproteobacteria
Order
Moraxellales
Family
Moraxellaceae
Genus
Acinetobacter
Description
Taxonomy
| Kingdom | Pseudomonadati |
|---|---|
| Phylum | Pseudomonadota |
| Class | Gammaproteobacteria |
| Order | Moraxellales |
| Family | Moraxellaceae |
| Genus | Acinetobacter |
| Species | Acinetobacter baumannii |
| Strain | strain ABNIH28 |
Profile
| Physiology | |
|---|---|
| Gram staining properties | Negative |
| Shape | Rod |
| Mobility | No |
| Flagellar presence | Yes |
| Number of membranes | 2 |
Image source: Wikipedia/Wikimedia
| Ecology, Host, and Life Cycle | |
|---|---|
| Oxygen requirements | Aerobe |
| Optimal temperature | 37 |
| Temperature range | Mesophilic |
| Habitat | Multiple |
| Biotic relationship | Free living |
| Host(s) | Homo sapiens, Gallus gallus, Bos taurus |
| Cell arrangement | Singles |
| Sporulation | Not Available |
| Energy source | Heterotroph - Chemoheterotroph |
| Pathogenicity | Human |
Genome Summary
Acinetobacter baumannii strain ABNIH28 plasmid pNDM-0285, complete
Gene Summary
Adenine Count
12067 bp
Thymine Count
12699 bp
Guanine Count
7085 bp
Cytosine Count
7508 bp
Genome Length
39359 bp
Protein-coding Genes
42 genes
Non-Coding Genes
0 genes
# of Chromosomes/Plasmids
3
Genes
| Name | Locus Tag | UniProt ID | Strand Orientation | Gene Start/End | Protein Molecular Weight |
|---|---|---|---|---|---|
| pyrimidine utilization protein d | C2U32_RS10975 | Not Available | Positive | 2218933 - 2219739 | 29984.9 |
| malonic semialdehyde reductase | C2U32_RS10980 | Not Available | Positive | 2219736 - 2220323 | 21775.1 |
| pyrimidine utilization protein a | C2U32_RS10985 | Not Available | Positive | 2220682 - 2221800 | 41584.7 |
| pyrimidine utilization protein b | C2U32_RS10990 | Not Available | Positive | 2221797 - 2222549 | 27446.7 |
| pyrimidine utilization protein c | C2U32_RS10995 | Not Available | Positive | 2222595 - 2222978 | 13624.2 |
| nadh-dependent fmn reductase rutf | C2U32_RS11000 | Not Available | Positive | 2223045 - 2223635 | 21372.7 |
| pyrimidine utilization transport protein g | C2U32_RS11005 | Not Available | Positive | 2223668 - 2225020 | 47227.0 |
| nad(p)-dependent oxidoreductase | C2U32_RS11010 | Not Available | Positive | 2225036 - 2225908 | 31792.4 |
| srpbcc family protein | C2U32_RS11015 | Not Available | Negative | 2225954 - 2226403 | 16575.9 |
| ygfz/gcvt domain-containing protein | C2U32_RS11020 | Not Available | Positive | 2226620 - 2227342 | 26756.6 |
Pathways
0 pathways
No pathways found
No metabolic pathways have been associated with this bacterium yet.
Health Effects
| Health Condition | Relation | Reference |
|---|---|---|
| Hospital-acquired pneumonia | Causes | PMC11264759 |
| Bacteremia | Causes | PMC11264759 |
| Urinary tract infections | Causes | PMC11264759 |
| Traumatic injuries | Causes | PMC11264759 |
| Respiratory tract infection | Causes | PMC11514839 |
| Healthcare-associated infections | Causes | PMC13168211 |
| Bacteremia | Causes | PMC10561989 |
| Hospital-acquired pneumonia | Causes | PMC11925754 |
| Bloodstream infections | Causes | PMC11925754 |
| Wound contaminations | Causes | PMC11925754 |

